Twitter | Search | |
Elevate Trader
Don't be a pawn in someone else's position. At Elevate Trader we always alert our community first! Do your own due diligence!
4,976
Tweets
38
Following
555
Followers
Tweets
Elevate Trader Jun 14
news is, "Bluegreen Vacations Corporation Enters into Settlement with Bass Pro to Reinstate Marketing Activities at all Retail Stores and Extend into the over 75 Cabela Retail Stores" 👀
Reply Retweet Like
Elevate Trader Jun 14
Participate in Arizona’s Industrial Hemp Program. 👀
Reply Retweet Like
Elevate Trader Jun 14
Announced Clinical Proof-of-Concept Data from Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies at the 2019 EHA Annual Meeting. 👀
Reply Retweet Like
Elevate Trader Jun 11
also looking for day 2. Keep a eye on it. News yesterday is below. 👀
Reply Retweet Like
Elevate Trader Jun 11
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Cannabidiol. 👀
Reply Retweet Like
Elevate Trader Jun 11
they Announced $2 Million Share Repurchase Program. 👀
Reply Retweet Like
Elevate Trader Jun 11
they Announces the Publication of CRV431 Data from Experimental Model of Hepatitis B. 👀
Reply Retweet Like
Elevate Trader Jun 11
Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2. 👀
Reply Retweet Like
Elevate Trader Jun 11
looking for day 2. The news yesterday is below. 👀
Reply Retweet Like
Elevate Trader Jun 11
Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication. also just had a 1-70 spilt. 👀
Reply Retweet Like
Elevate Trader Jun 10
@luv2rip a monster!
Reply Retweet Like
Elevate Trader Jun 10
rebounding pre market after the hatchet job from Aurelius on Friday. 👀
Reply Retweet Like
Elevate Trader Jun 10
Announced Share Repurchase Program; Reiterates Positive Business Fundamentals and Strong Financial Position. 👀
Reply Retweet Like
Elevate Trader Jun 10
Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions. 👀
Reply Retweet Like
Elevate Trader Jun 10
headline is "A Single Course of Provention's PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least Two Years" 👀
Reply Retweet Like
Elevate Trader Jun 10
they announced that Avenova® Direct is available at affordable pricing and without a prescription on through the Company’s new direct-to-consumer online channel. 👀
Reply Retweet Like
Elevate Trader Jun 7
on watch, Neptune Wellness signs 3-year extraction, purification deal with cannabis company Tilray. 👀
Reply Retweet Like
Elevate Trader Jun 7
company on Thursday announced the receipt of FDA approval for a non-adjunctive indication for the Eversense 90-day CGM system. 👀
Reply Retweet Like
Elevate Trader Jun 7
News*
Reply Retweet Like
Elevate Trader Jun 7
Restoration Robotics® and Venus Concept Provide Merger Update. 👀
Reply Retweet Like